Skip to main content
Clinical Trials/NCT00509054
NCT00509054CompletedPhase 4

Randomised Clinical Trial of the Use of a Prosthetic Mesh to Prevent Parastomal Hernia

Sundsvall Hospital2 sites in 1 country54 target enrollmentStarted: January 1, 2001Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
54
Locations
2
Primary Endpoint
Wound infection,mesh infection, parastomal hernia.

Study Overview

Brief Summary

Parastomal hernias are randomised to either a conventional stoma formed through the rectus anterior muscle or to the same procedure with the addition of a prophylactic mesh in a sublay position.

Detailed Description

Parastomal hernias are randomised to either a conventional stoma formed through the rectus anterior muscle or to the same procedure with the addition of a prophylactic mesh in a sublay position. Randomisation is by opening closed envelopes.

A low-weight,partly absorbable mesh is used. Patients are followed for 5 years. Clinical follow up after one month to register early complications such as wound infection or mesh infection.

Clinical follow up after 12 months to register parastomal herniation, fistula formation, stenosis.

Clinical follow up after 5 years to register parastomal herniation, fistula formation, stenosis. At this clinical follow up radiologic examination is added.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Clinical need of an enterostoma

Exclusion Criteria

  • Patients denies inclusion in the trial.

Outcomes

Primary Outcomes

Wound infection,mesh infection, parastomal hernia.

Time Frame: Within five years

Secondary Outcomes

  • Fistula formation, stenosis,pain.(Within five years)

Investigators

Sponsor
Sundsvall Hospital
Sponsor Class
Other

Study Sites (2)

Loading locations...

Similar Trials